Nanomedicine and Nanotechnology
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
”Nanomedicine and Nanotechnology” is a new section of the peer-reviewed open access journal Pharmaceutics, which is focused on all aspects and applications of innovative nanosystems.
The main aims of this section are to highlight and collect recent progress in nanotechnology and its applications in pharmaceutical, clinical, diagnostic, environmental, and cosmetic fields.
Covered topics include the following:
- Advances in methodologies for characterization of nanocarriers
- Nanodevices and nanosensors
- Stability studies
- Development of new drug delivery systems
- Nanotoxicity
- Skin and mucosal application
- Nanotechnology in tissue engineering and regenerative nanomedicine
- Functionalization for a selective target
- Nanodelivery systems in cosmeceutical and nutraceutical field
- Nanodelivery as a strategy to improve bioavailability
- Strategies and formulations for controlled drug release
- In vivo testing
The section encourages the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields. Authors will enjoy a high-quality reviewing process, rapid publication, and high visibility from access to a broad readership.
Review, original research papers, communications, short communications, opinions, or technical notes will be considered for publication.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Applications of Nanomaterials in Immunotherapies (Deadline: 31 May 2026)
- New Delivery Strategy Based on Magnetic Nanoparticles for Disease Treatment (Deadline: 31 May 2026)
- Graphene and Graphene Family Nanomaterials for Biomedical Applications (Deadline: 31 May 2026)
- Micro- and Nanoemulsion-Based Systems for Controlled and Targeted Drug Delivery (Deadline: 31 May 2026)
- Medical Applications of Chitosan Nanoparticles (Deadline: 20 June 2026)
- Functional Nanomaterials in Pharmaceutics: Current Uses and Potential Applications (Deadline: 20 June 2026)
- State of the Art of Nano-Based Wound Dressings (Deadline: 30 June 2026)
- Multifunctional Nanomaterials in Drug Delivery (Deadline: 30 June 2026)
- Metal Nanoparticles for Controlled Release of Drugs and Bioactive Compounds (Deadline: 30 June 2026)
- Sustainable Nanotechnologies Derived from Renewable Resources for Advanced Drug Design, Delivery and Therapy (Deadline: 30 June 2026)
- Pharmaceutical Innovations in Micro- and Nanotechnology for Topical and Transdermal Delivery of Synthetic and Biotechnological Molecules, and Herbal Extracts (Deadline: 30 June 2026)
- Nanomedicines for Immunotherapy (Deadline: 30 June 2026)
- Synthesis of Microfluidic-Based Nanoparticles and Their Potential Applications in Drug Delivery Systems (Deadline: 30 June 2026)
- Pharmaceutical Nanotechnology for the Treatment of Leishmaniasis and Chagas Diseases (Deadline: 30 June 2026)
- Development of New Nanotechnological Systems Loaded with Drugs for Infectious Disease Application, 2nd Edition (Deadline: 30 June 2026)
- Biomimetic Nanoparticles for Disease Treatment and Diagnosis (Deadline: 30 June 2026)
- Polymer Nanoparticles in Cancer Therapy (Deadline: 10 July 2026)
- Advanced Nanoencapsulation Platforms for Bioactive Compounds and Drugs in Pain Therapy (Deadline: 20 July 2026)
- Biocompatible Smart Liposomes as a Cutting-Edge Therapeutic Strategy (Deadline: 20 July 2026)
- Biomaterial-Based Nanoencapsulation Systems for Drug Protection and Controlled Release (Deadline: 20 July 2026)
- Carbon-Based Nanomaterials for Pharmaceutical Applications (Deadline: 30 July 2026)
- Nanomedicine and Nanotechnology: Recent Advances and Applications (Deadline: 31 July 2026)
- Engineering and Characterisation of Novel Nanomedicine Formulations, 3rd Edition (Deadline: 31 July 2026)
- Advanced Nano-Formulations for Drug Delivery and Cancer Immunotherapy (Deadline: 31 July 2026)
- Advances in Nanoparticle-Driven Approaches for Targeted Brain Drug Delivery (Deadline: 31 July 2026)
- Advances and Challenges in Nanomedicine: Translating Nanotechnology into Therapeutics for Cancer, Neurodegenerative, and Infectious Diseases (Deadline: 31 July 2026)
- Research on Protein-Based Nanoparticles and Their Pharmaceutical Applications (Deadline: 10 August 2026)
- Recent Advances in Chitosan-Based Nanoparticles for Drug Delivery (Deadline: 20 August 2026)
- Nanomedicines in Cancer Therapy, 2nd Edition (Deadline: 20 August 2026)
- Innovative Nano-Delivery Systems for Enhanced Oral Disease Therapies (Deadline: 23 August 2026)
- ROS-Mediated Nano Drug Delivery for Antitumor Therapy (Deadline: 28 August 2026)
- Hybrid Nanoparticles for Cancer Therapy, 2nd Edition (Deadline: 31 August 2026)
- Advanced Theranostic Nanoplatforms for Precision Therapy (Deadline: 31 August 2026)
- Surface-Engineered Nanomedicines for Imaging-Guided Delivery and Enhanced Therapeutic Performance (Deadline: 31 August 2026)
- Metallic Nanoparticles for Pharmaceutical Applications (Deadline: 31 August 2026)
- Emerging Trends in Nanocarriers for Therapeutic and Diagnostic Purposes (Deadline: 31 August 2026)
- Oral Nanomedicine for Peptide and Protein Delivery (Deadline: 31 August 2026)
- Nanoparticles for Glioblastoma Therapy (Deadline: 31 August 2026)
- Antibacterial Nanoformulations Based on Natural Products (Deadline: 20 September 2026)
- Nanoadjuvants for Drug Delivery and Immunotherapy (Deadline: 30 September 2026)
- Conjugated Polymer Nanoparticles: Innovative Designs for Photodynamic and Photothermal Therapy in Cancer and Bacterial Infections—Preclinical Evaluation and Beyond (Deadline: 30 September 2026)
- Advanced Nanomaterials for Drug Delivery, 2nd Edition (Deadline: 30 September 2026)
- Synergistic Nanomedicines: Integrating Chemotherapy and Phototherapy for Enhanced Cancer Treatment (Deadline: 30 September 2026)
- Nanoemulsions for Nose-to-Brain Drug Delivery (Deadline: 30 September 2026)
- Drug Nanocarriers for Pharmaceutical Applications, 2nd Edition (Deadline: 30 September 2026)
- Nanoparticles in Photodynamic Therapy (Deadline: 30 September 2026)
- Integrating Phytocompounds with Nanotechnology: Revolutionary Approaches to Antimicrobial, Antioxidant, and Anti-Tumoral Therapies (Deadline: 30 September 2026)
- Advances in Bioactive Compounds and Nanotechnology: Sustainable Approaches for Pharmaceutical Applications (Deadline: 30 September 2026)
- Emerging Trends in Smart Theranostic Nanomedicine (Deadline: 30 September 2026)
- Functional Nanomaterials in Pharmaceutical and Biomedical Applications (Deadline: 30 September 2026)
- Inflammation-Targeted Nanomedicines for the Treatment of Chronic Inflammatory Diseases and Cancer (Deadline: 30 September 2026)
- Biopolymer Nanoparticles for Targeted Therapy in Cardiovascular Diseases (Deadline: 20 October 2026)
- Advanced Nanotechnology-Based Strategies for Ocular Diseases Treatment (Deadline: 20 October 2026)
- Nanocarrier-Based Precision Therapeutics for Chronic Lung Diseases: Emerging Strategies and Translational Advances (Deadline: 31 October 2026)
- Advanced Nano-Based Drug Delivery Systems for Infectious Diseases (Deadline: 31 October 2026)
- Nanostructured Therapeutics and Diagnostic Platforms for Tumor Microenvironment Modulation and Precision Cancer Therapy (Deadline: 31 October 2026)
- Advanced Drug Nanocrystals (Deadline: 31 October 2026)
- Metal–Organic Frameworks for Pharmaceutical Applications (Deadline: 31 October 2026)
- New Era in Antimicrobial Strategies (Deadline: 31 October 2026)
- Recent Advances in Biomaterials for Wound Management: Synthesis, Design and Application (Deadline: 31 October 2026)
- Advances in Nanotechnology-Based Drug Delivery Systems, 2nd Edition (Deadline: 31 October 2026)
- Multifunctional Nanoparticles: Diagnostics, Therapy, and Beyond (Deadline: 20 November 2026)
- Nano-Lipid Carriers for the Treatment of Neurological Diseases (Deadline: 31 December 2026)
- Nanotechnology and Pharmaceutical Innovations in Oral Diseases (Deadline: 31 December 2026)
- Gold Nanoparticles in Cancer Photothermal Therapy: Current Trends and Future Directions (Deadline: 31 December 2026)
- Nanotechnology and Cell Therapies for Ocular Diseases (Deadline: 31 December 2026)
- Nanotechnology for the Prevention, Diagnosis, and Therapy of HIV, HCV, and Coinfection: From Bench to Bedside (Deadline: 31 December 2026)
- Dendrimer-Mediated Drug, Gene, and Protein Delivery for Disease Treatment (Deadline: 31 December 2026)
- Nanocarriers and Delivery Systems for Next-Generation Nanomedicine Therapies (Deadline: 31 December 2026)
- Nanocarriers in Cardiovascular Medicine: Current Applications and Future Perspectives (Deadline: 31 December 2026)
- Dendrimers in Nanomedicine: Recent Advances (Deadline: 16 January 2027)
- Functionalized Metal Nanoparticles in Cancer Therapy (Deadline: 20 January 2027)
- Advanced Nanomaterials and Drug Delivery Systems for Wound Healing and Antimicrobial Therapy (Deadline: 20 January 2027)
- New Insights into Nanomaterials for Cancer Therapy and Drug Delivery (Deadline: 31 January 2027)
- Combining Ultrasound and Microbubbles/Nanobubbles for Enhancing the Effects of Cancer Therapies (Deadline: 31 January 2027)
- Applications of Nanotechnology in Veterinary Drug Delivery (Deadline: 20 February 2027)
- Precision Nanomedicine for Immunotherapy (Deadline: 31 March 2027)
- Nanogels: An Innovative Approach to Personalized Medicine (Deadline: 31 March 2027)
- Emerging Stimuli-Responsive Nanoparticles for Bioactive Delivery (Deadline: 31 March 2027)
- Natural Products and Their Bioinspired Nanodelivery Systems for Immune Microenvironment Modulation (Deadline: 31 May 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
